a 2023

Abstract 15489: Clinical Characteristics and Outcome of Patients With Acute Myocardial Infarction and Pre-Existing Left Heart Valvular Disease

MUZAFAROVA, Tamilla, Zuzana MOTOVSKA, Ota HLINOMAZ, Milan HROMADKA, Petr KALA et. al.

Basic information

Original name

Abstract 15489: Clinical Characteristics and Outcome of Patients With Acute Myocardial Infarction and Pre-Existing Left Heart Valvular Disease

Authors

MUZAFAROVA, Tamilla, Zuzana MOTOVSKA, Ota HLINOMAZ (203 Czech Republic, belonging to the institution), Milan HROMADKA, Petr KALA (203 Czech Republic, belonging to the institution), Teodora VICHOVA, Jan MROZEK, Jiri KETTNER, Martin HUTYRA, Robert PETR, Pavol TOMASOV, Oana IONITA and Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution)

Edition

ACUTE CORONARY SYNDROMES 2023, 2023

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.300 in 2022

RIV identification code

RIV/00216224:14110/23:00133234

Organization unit

Faculty of Medicine

ISSN

Keywords (in Czech)

Clinical Characteristics; Acute Myocardial Infarction; Pre-Existing Left Heart Valvular Disease

Keywords in English

Clinical Characteristics; Acute Myocardial Infarction; Pre-Existing Left Heart Valvular Disease

Tags

Tags

International impact, Reviewed
Změněno: 8/4/2024 14:45, Mgr. Tereza Miškechová

Abstract

V originále

Introduction. With the aging population and rising prevalence of cardiovascular risk (CV) factors, the global number of patients with acute myocardial infarction (AMI) and left valvular heart disease (VHD) is expected to increase substantially. Aims: To analyze the impact of pre-existing significant mitral regurgitation (MR) and aortic stenosis (AS) on clinical characteristics and outcome of AMI.

Links

90249, large research infrastructures
Name: CZECRIN IV